Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
SAN JOSE, Calif., Dec. 6, 20203. Anixa Biosciences ( " Anixa " or the " Company " ), a biotechnology company focused on the treatment and prevention of cancer, today announced new and updated positive results from the Phase 1 clinical trial of its...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Pharmaceuticals | Study | Vaccines